IDXX

Q: What is the price of IDEXX Laboratories (IDXX) today?

A cotação de IDEXX Laboratories (IDXX) hoje está em $ 560.11, com uma variação de The stock began the year trading around $ 676.53 and is currently priced at $ 560.11. negociando na casa dos $ 676.53 e hoje está em $ 560.11. Acompanhe o and track broader market trends directly on the platform.

Q: When does IDEXX Laboratories (IDXX) pay dividends?

IDEXX Laboratories (IDXX) did not pay dividends over the past year.

Q: Is IDEXX Laboratories (IDXX) a good investment?

Atualmente, IDEXX Laboratories (IDXX) está cotada a $ 560.11, com um P/L de 40.91, This represents a 4,718% premium compared to its historical average P/E. uma variação de 13.91 em sua cotação e distribuiu $ 0.00 em dividendos, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 13.91%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

IDEXX Laboratories Inc.

Price

$ 560.11

return (12m)

13.91%

p/e

40.91

p/bv

28.80

DIVIDEND YIELD

0.00%

IDXX price

IDXX

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment IDXX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-0.51%

3 months

-12.45%

1 year

13.91%

2 years

9.86%

5 years

9.33%

10 years

546.26%

Fundamentals IDXX

review the fundamentals of IDEXX Laboratories shares

P/E

40.91

Sector: -236.86 Industry: 1.11

P/S (PSR)

10.08

Sector: 1.41 Industry: 2.48

P/BV

28.80

Sector: 0.44 Industry: 2.27

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

32.35%

Sector: -172.33% Industry: -24.38%

ROE

70.38%

Sector: -398.12% Industry: -31.44%

ROIC

40.66%

Sector: -428.36% Industry: -81.70%

NET MARGIN

24.63%

Sector: -51.44% Industry: -31.09%

GROSS MARGIN

62.05%

Sector: 27.46% Industry: 51.18%

OPERATING MARGIN

31.63%

Sector: -47.58% Industry: -27.87%

EV/EBITDA

29.52

Sector: -221.25 Industry: 1.15

EV/EBIT

31.83

Sector: -229.16 Industry: -0.08

PRICE-TO-ASSETS

13.24

Sector: 0.72 Industry: 1.21

BVPS

19.45

Sector: -2.82 Industry: 4.85

EPS

13.69

Sector: -9,587.37 Industry: -0.70

EQUITY-TO-ASSETS RATIO

0.46

Sector: -0.01 Industry: 0.45

LIABILITIES / ASSETS

0.54

Sector: 0.30 Industry: 0.50

CAGR REVENUE 5 YEARS

6.70%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

8.02%

Sector: - Industry: -

FAIR VALUE OF IDEXX Laboratories ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 560.11

Fair Value

$ 0.00

Upside/Downside Return potential.

-86.18%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals IDXX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	33.59	27.21	81.01%	0.66%	$ 848.86 B	34.98%
ISRG	53.63	9.08	16.93%	0.00%	$ 159.77 B	28.15%
TMO	25.26	3.32	13.15%	0.38%	$ 172.98 B	15.15%
SNY	11.59	1.26	10.86%	5.11%	$ 105.72 B	18.68%
NVS	20.60	7.16	34.77%	2.12%	$ 278.77 B	23.92%
ABT	25.14	0.00	0.00%	2.64%	$ 157.79 B	13.91%
MDT	21.18	1.99	9.38%	3.73%	$ 97.70 B	13.00%
GSK	12.93	4.37	33.77%	3.48%	$ 101.42 B	17.79%
CVS	39.31	1.48	3.78%	2.94%	$ 115.27 B	0.72%
BSX	22.46	0.00	0.00%	0.00%	$ 80.09 B	17.29%
TMDX	13.42	4.67	34.80%	0.00%	$ 2.31 B	27.04%
HCA	14.35	-32.73	-228.14%	0.68%	$ 97.48 B	8.89%
RMD	19.73	4.62	23.41%	1.13%	$ 29.98 B	27.44%
DHR	32.85	2.29	6.97%	0.79%	$ 121.18 B	14.89%
INMD	10.09	1.33	13.18%	0.00%	$ 879.48 M	23.27%
PHG	22.93	1.96	8.56%	3.26%	$ 25.90 B	5.50%
SYK	32.76	4.76	14.52%	1.21%	$ 109.34 B	13.21%
FMS	11.00	0.74	6.71%	3.57%	$ 12.12 B	4.89%
UHS	6.82	1.36	20.00%	0.47%	$ 10.37 B	8.56%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

IDXX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT IDEXX Laboratories

IDEXX Laboratories Inc.

Average Investor10 user rating

5.0 (31 people)

United States

43 years

Founded: 1983

1991

Time since IPO - 35 years

10.350

Employees

IDEXX Laboratories Inc. (United States) is listed on the Nasdaq and has a market capitalization of $44.81 Billions, with shareholders equity totaling $1.56 Billion.

The company employs approximately 10.350 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, IDEXX Laboratories Inc. reported $4.45 Billions in revenue, generating net income of $1.10 Billion.

Key financial metrics include a P/E ratio of 40.91, a price-to-book (P/B) ratio of 28.80, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker IDXX.

Market cap

$ 44.81 Billions

Net worth

$ 1.56 Billion

$ 1,556,100,000.00

Assets

$ 3.39 Billions

$ 3,385,500,000.00

Total Shares Outstanding

80.00 Millions

80,000,000

Average Daily Trading Volume

$ 549.75 Thousand

$ 549,753.34

Sector

Health

Industry

Medical Supplies and Equipment

IDXX

revenue by Business Segment IDEXX Laboratories

Revenue by Region IDEXX Laboratories

IDXX revenue and profits

Financial Results IDXX

DRAG THE FRAME TO SEE MORE DATA

IDXX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 90.55 40,16% (12M)

P/E

39.31

2.94%

ROE

3.78%

P/BV

1.48

CI - Cigna

$ 288.06 --11,31% (12M)

P/E

10.52

2.11%

ROE

16.97%

P/BV

1.79

CNC - Centene

$ 55.96 --10,88% (12M)

P/E

-4.27

0.00%

ROE

-29.93%

P/BV

1.28

HUM - Humana

$ 274.96 12,29% (12M)

P/E

29.20

1.29%

ROE

6.06%

P/BV

1.77

LLY - Eli Lilly

$ 948.45 26,67% (12M)

P/E

33.59

0.66%

ROE

81.01%

P/BV

27.21

HCA - HCA Healthcare

$ 435.19 24,09% (12M)

P/E

14.35

0.68%

ROE

-228.14%

P/BV

-32.73

NVS - Novartis

$ 146.03 36,97% (12M)

P/E

20.60

2.12%

ROE

34.77%

P/BV

7.16